Product Description
Hot Selling PSA Prostate Specific Antigen Test Cassette
A rapid test for the semi-quantitative detection of prostate specific antigen (PSA) in whole blood,
serum or plasma.
For professional in vitro diagnostic use only.
1) INTENDED USE
Hot Selling PSA Prostate Specific Antigen Test Cassette is
a rapid chromatographic immunoassay for semi-quantitative detection of Prostate Specific Antigen in
whole blood, serum or plasma.
2) SUMMARY
Prostate specific antigen (PSA) is produced by prostate glandular and endothelial cells. It is a single
chain glycoprotein with a molecular weight of approximately 34 kDa.1 PSA exists in three major
forms circulating in the serum. These forms are free PSA, PSA bound to α1 - Antichymotrypsin
(PSA-ACT) and PSA complexed with α2-macroglobulin (PSA-MG).2
PSA has been detected in various tissues of the male urogenital system but only prostate glandular and
endothelial cells secrete it. The PSA level in serum of healthy men is between 0.1 ng/mL and
2.6 ng/mL. It can be elevated in malignant conditions such as prostate cancer, and in benign condition
such as benign prostatic hyperplasia and prostatitis. A PSA level of 4 to 10 ng/mL is considered to be
in the "gray-zone" and levels above 10 ng/mL are highly indicative of cancer.3 Patients with PSA
values between 4-10 ng/mL should undergo further analysis of the prostate by biopsy.
The prostate specific antigen test is the most valuable tool available for the diagnosis of early prostate
cancer. Many studies have confirmed that the presence of PSA is the most useful and meaningful tumor
marker known for prostate cancer and prostate infection of Benign Prostatic Hyperplasia (BPH).4
The PSA Prostate Specific Antigen Semi-Quantitative Rapid Test Device (Whole Blood/Serum/Plasma)
utilizes a combination of colloidal gold conjugate and anti-PSA antibodies to selectively detect total PSA in
whole blood, serum or plasma. The test has a cut-off value of 4 ng/mL and a reference value of 10 ng/mL.
3) PRINCIPLE
Prostate Specific Antigen Rapid Test Device PSA Detection in Whole Blood/Serum/Plasmais
a semi-quantitative, membrane based immunoassay for the detection of PSA in whole blood, serum or
plasma. The membrane is pre-coated with PSA antibodies on the test line region. During testing, the
specimen reacts with the particle coated with anti-PSA antibody. The mixture migrates upward on the
membrane chromatographically by capillary action to react with anti-PSA antibodies on the membrane
and generate a colored line. A test line (T) intensity weaker than the reference line (R) indicates that
the PSA level in the specimen is between 4-10 ng/mL. A test line (T) intensity equal or close to the
reference line (R) indicates that the PSA level in the specimen is approximately 10 ng/mL. A test line
(T) intensity stronger than the reference line (R) indicates that the PSA level in the specimen is above
10 ng/mL. To serve as a procedural control, a colored line will always appear in the control line region
(C) indicating that proper volume of specimen has been added and membrane wicking has occurred.
4) STORAGE AND STABILITY
Store as packaged in the sealed pouch either at room temperature or refrigerated (2-30°C). The test is
stable through the expiration date printed on the sealed pouch. The test must remain in the sealed
pouch until use. DO NOT FREEZE. Do not use beyond the expiration date.
5) SPECIMENS COLLECTION AND PREPARATION
The PSA Prostate Specific Antigen Semi-Quantitative Rapid Test Device (Whole Blood/Serum/Plasma)
can be performed using whole blood (from venipuncture or fingerstick), serum, or plasma.
To collect Fingerstick Whole Blood specimens:
Wash the patient's hand with soap and warm water or clean with an alcohol swab. Allow to dry.
Massage the hand without touching the puncture site by rubbing down the hand towards the
fingertip of the middle or ring finger.
Puncture the skin with a sterile lancet. Wipe away the first sign of blood.
Gently rub the hand from wrist to palm to finger to form a rounded drop of blood over the
puncture site.
Add the Fingerstick Whole Blood specimen to the test by using a capillary tube:
Touch the end of the capillary tube to the blood until filled to approximately 80 μL. Avoid air
bubbles.
Place the bulb onto the top end of the capillary tube, then squeeze the bulb to dispense the
whole blood onto the specimen well (S) of the test device.
Add the Fingerstick Whole Blood specimen to the test by using hanging drops:
Position the patient's finger so that the drop of blood is just above the specimen well (S) of the
test device.
Allow 2 hanging drops of fingerstick whole blood to fall onto the specimen well (S) of the test
device, or move the patient's finger so that the hanging drop touches the specimen well (S).
Avoid touching the finger directly to the specimen well (S).
Separate serum or plasma from blood as soon as possible to avoid hemolysis. Use only clear, nonhemolyzed
specimens.
Testing should be performed immediately after specimen collection. Do not leave the specimens at room temperature for prolonged periods. Serum and plasma specimens may be stored at 2-8°C for up to 3 days. For long term storage, specimens should be kept below -20°C. Whole blood collected by venipuncture should be stored at 2-8°C if the test is to be run within 2 days of collection. Do not freeze whole blood specimens. Whole blood collected by fingerstick should be tested immediately.
Bring specimens to room temperature prior to testing. Frozen specimens must be completely thawed and mixed well prior to testing. Specimens should not be frozen and thawed repeatedly.
If specimens are to be shipped, they should be packed in compliance with local regulations covering the transportation of etiologic agents.
6) MATERIALS
A. Materials Provided
Test devices Droppers Buffer Package insert
B. Materials Required But NOT Provided
Timer Specimen collection containers Lancets (for fingerstick whole blood only)
Heparinized capillary tubes and dispensing bulb (for fingerstick whole blood only)
Centrifuge
7) DIRECTION FOR USE
Allow the test, specimen, buffer and/or controls to equilibrate to room temperature (15-30°C)
prior to testing.
1. Bring the pouch and buffer to room temperature before opening pouch. Remove the test device
from the sealed pouch and use it as soon as possible.
2. Place the test device on a clean and level surface.
For Serum, Plasma or Venipuncture Whole Blood specimens:
Hold the dropper vertically and transfer 1 drop of serum, plasma (approximately 40 μL) or 2 drops of
venipuncture whole blood (approximately 80 μL) to the specimen well (S) of the test device, then add 1 drop of buffer (approximately 40 μL) and start the timer. See illustration below.
For Fingerstick Whole Blood specimens:
To use a capillary tube: Fill the capillary tube and transfer approximately 80 μL of fingerstick
whole blood specimen to the specimen well (S) of the test device, then add 1 drop of buffer
(approximately 40 μL) and start the timer. See illustration below.
To use hanging drop: Allow 2 hanging drops of fingerstick whole blood specimen
(approximately 80 μL) to fall into the center of the specimen well (S) of the test device, then add
1 drop of buffer (approximately 40 μL) and start the timer. See illustration below.
3. Wait for the colored line(s) to appear.* Read the result at 5 minutes. Do not interpret the result
after 10 minutes.
*Note: If migration is not observed in the result window after 30 seconds, add one or two extra
drops of buffer.
8) INTERPRETATION OF RESULTS
(Please refer to the illustration above)
POSITIVE: Three distinct colored lines appear.
A. A test line (T) intensity weaker than the reference line (R) indicates a PSA level between 4-10 ng/mL.
B. A test line (T) intensity equal or close to the reference line (R) indicates a PSA level of
approximately 10 ng/mL.
C. A test line (T) intensity stronger than the reference line (R) indicates a PSA level above 10 ng/mL
.
NEGATIVE: Colored lines appear in both the control (C) and reference (R) regions. No
apparent colored line appears in the test line region (T). This indicates a PSA level below 4 ng/mL.
INVALID: Control line (C) or reference line (R) fail(s) to appear. Insufficient specimen volume or
incorrect procedural techniques are the most likely reasons for control line and reference line failure.Review the procedure and repeat the test with a new test. If the problem persists, discontinue using the test kit immediately and contact your local distributor.
9) QUALITY CONTROL
A procedural control is included in the test. The appearance of colored lines in the control line
region (C) and reference line region (R) is considered a procedural controls. It confirms sufficient
specimen volume, adequate membrane wicking and correct procedural technique.
Control standards are not supplied with this kit; however, it is recommended that positive and
negative controls be tested as a good laboratory practice to confirm the test procedure and to verify
proper test performance.
10) CLINICAL SENSITIVITY, SPECIFICITY AND ACCURACY
The PSA Prostate Specific Antigen Semi-Quantitative Rapid Test Device (Whole Blood/Serum/
Plasma) has been tested with a leading commercial PSA EIA Test using clinical samples.
Relative Sensitivity: 98.7% (95.4%-99.8%)*
Relative Specificity: 98.5% (96.3%-99.6%)*
Relative Accuracy: 98.6% (97.0%-99.5%)*
We are a supplier of rapid test kits products in China . Focus areas are one step Fertility Test Kits, One Step Drug of Abuse Test Kits , One Step Cardiac Marker Test Kits, One Step Infectious Disease Test Kits and One Step Tumor Marker Test Kits . Welcome to contact us as following for our Newest Product Catalogue :
TEL: +86-571-87352763
FAX:+86-571-87352130
Other Products available in our factory :
Tumor Markers Rapid Test |
Catalog No. | Product name | Specimen | Format | Sensitity | CE | SFDA |
TFOB-16 | FOB Fecal Occult Blood Test | Feces | Strip/Cassette | 50/200ng/ml | | √ |
TAFP-14 | AFP Alpha-Fetoprotein Test | WB/S/P | Strip/Cassette | | | |
TCEA-14 | CEA Carcinoembryonic Antigen Test | WB/S/P | Strip/Cassette | | | |
TPSA-14 | PSA Prostate Specific Antigen Test | WB/S/P | Strip/Cassette | | | |
|
Cardiac Markers Rapid Test |
Catalog No. | Product name | Specimen | Format | Sensitity | CE | SFDA |
CTI-402 | TnI One Step Troponin I Test | WB/S/P | Strip/Cassette | 0.5ng/ml | | √ |
CMA-435 | Myoglobin/CK-MB/Troponin I Combo Test | WB/S/P | Strip/Cassette | see insert | | √ |
|
Fertility Rapid Test |
Catalog No. | Product name | Specimen | Format | Sensitity | CE0197 | SFDA |
FHCG-11 | hCG Pregnancy Test | Urine | Strip/Cassette/Midstream | 10/25mIU/ml | √ | √ |
FHCG-12 | hCG Pregnancy Test | Urine/Serum | Strip/Cassette/Midstream | 25mIU/ml | | √ |
FLH-11 | LH Ovulation Test | Urine | Strip/Cassette/Midstream | 20/25mIU/ml | √ | √ |
FFSH-11 | FSH Menopause Test | Urine | Strip/Cassette/Midstream | 25mIU/ml | | |
Infectious Disease Rapid Test |
Catalog No. | Product name | Specimen | Format | CE | SFDA |
IDEAB-13 | Dengue IgG/IgM Test | Serum/Plasma | Cassette | √ | |
IDEAG-14 | Dengue NS1 Antigen Test | Whole Blood/Serum/Plasma | Strip/Cassette | √ | |
IDEN-14 | Dengue IgG/IgM/NS1 Antigen Test | Whole Blood/Serum/Plasma | Cassette | √ | |
IHAV-14 | HAV Hepatitis A Virus IgG/IgM Test | Whole Blood/Serum/Plasma | Cassette | | |
IHBsg-14 | HBsAg Hepatitis B Surface Antigen Test | Whole Blood/Serum/Plasma | Strip/Cassette | | √ |
IHBsb-14 | HBsAb Hepatitis B Surface Antibody Test | Whole Blood/Serum/Plasma | Strip/Cassette | | |
IHCV-14 | HCV Hepatitis C Virus Test | Whole Blood/Serum/Plasma | Strip/Cassette | | √ |
IHIV-14 | HIV 1/2 Test | Whole Blood/Serum/Plasma | Strip/Cassette | | |
IHIV-M14 | HIV 1/2 Tri-line Test | Whole Blood/Serum/Plasma | Cassette | | |
IHPab-14 | H.Pylori Ab Test | Whole Blood/Serum/Plasma | Strip/Cassette | √ | √ |
IHPag-14 | H.Pylori Ag Test | Feces | Strip/Cassette | √ | Pending |
IROT-16 | Rotavirus Test | Feces | Strip/Cassette | | |
IADE-16 | Adenovirus Test | Feces | Strip/Cassette | | |
IRAV-16 | Rotavirus/Adenovirus Combo Test | Feces | Cassette | | |
IFLUA-18 | Influenza A | Secretion | Strip/Cassette | | |
IFLUB-18 | Influenza B | Secretion | Strip/Cassette | | |
ILEI-13 | Leishmania IgG/IgM Test | Serum/Plasma | Cassette | | |
ILEP-13 | Leptospira IgG/IgM Test | Serum/Plasma | Cassette | | |
IMA-Fg14 | Malaria Ag p.f Test Cassette | Whole Blood | Strip/Cassette | √ | |
IMA-Vg14 | Malaria Ag p.v Test Cassette | Whole Blood | Strip/Cassette | √ | |
IMA-Tg14 | Malaria Ag P.f/P.v Tri-line Test Cassette | Whole Blood | Cassette | √ | |
IMA-Tb14 | Malaria Ab P.f/P.v Tri-line Test Cassette | Whole Blood | Cassette | √ | |
IMA-P14 | Malaria P.f./Pan Tri-line Test Cassette | Whole Blood | Cassette | √ | |
ITB-14 | TB Tuberculosis Test | Whole Blood/Serum/Plasma | Strip/Cassette | | |
ITOX-14 | Toxo IgG/IgM Test | Whole Blood/Serum/Plasma | Cassette | | |
ITP-14 | Syphilis Test | Whole Blood/Serum/Plasma | Strip/Cassette | √ | √ |
ITY-14 | Typhoid IgG/IgM Test Cassette | Whole Blood/Serum/Plasma | Cassette | | |
ITOM-345 | ToRCH Toxo/Rubella/CMV/HSV 1/2 IgM Antibodies Combo Test Device | Whole Blood/Serum/Plasma | Cassette | | |
IMC-435 | MCT HBsAg/HCV/HIV Multi Combo Test | Whole Blood/Serum/Plasma | Cassette | | |
IBR-14 | Brucellosis (Brucella) IgG/IgM Test | Whole Blood/Serum/Plasma | Cassette | | |
ICHA-14 | Chikungunya IgM Test | Whole Blood/Serum/Plasma | Strip/Cassette | | |
ICPab-14 | Chlamydia Pneumoniae Ab Test | Whole Blood/Serum/Plasma | Strip/Cassette | | Pending |
ICTag-18 | Chlamydia Trachomatis Ag Test | Secretion | Strip/Cassette | | Pending |
IMPab-14 | Mycoplasma Pneumoniae IgM Ab Test | Whole Blood/Serum/Plasma | Strip/Cassette | | Pending |
INGHag-18 | Neisseria Gonorrhoeae Ag Test | Secretion | Strip/Cassette | | Pending |
ITSH-13 | Neonatal TSH Test | Serum/Plasma | Strip/Cassette | | |
Drug of Abuse Rapid Test |
Catalog No. | Product name | Specimen | Format | Cut off | CE | SFDA |
DMOP-11 | MOP Morphine Test | Urine | Strip/Cassette/Dipcard | 100/200/300ng/ml | √ | √ |
DMET-11 | MET Methamphetamine Test | Urine | Strip/Cassette/Dipcard | 300/500/1000ng/ml | √ | √ |
DTHC-11 | THC Marijuana Test | Urine | Strip/Cassette/Dipcard | 50ng/ml | √ | √ |
DKET-11 | KET Ketamine Test | Urine | Strip/Cassette/Dipcard | 500/1000ng/ml | √ | √ |
DMDMA-11 | MDMA Ecstasy Test | Urine | Strip/Cassette/Dipcard | 500ng/ml | √ | √ |
DCOC-11 | COC Cocaine Test | Urine | Strip/Cassette/Dipcard | 100/300ng/ml | √ | √ |
DAMP-11 | AMP Amphetamine Test | Urine | Strip/Cassette/Dipcard | 500/1000ng/ml | √ | Pending |
DBZO-11 | BZO Benzodiazepines Test | Urine | Strip/Cassette/Dipcard | 200/300ng/ml | √ | Pending |
DOA-21 | MOP-MET 2 IN1 Test | Urine | Cassette/Dipcard | Same as single | √ | √ |
DOA-31 | MOP-MET-KET 3 IN 1 Test | Urine | Cassette/Dipcard | Same as single | √ | √ |
DOA-51 | MOP-MET-KET-THC-MDMA 5 IN 1 Test | Urine | Cassette/Dipcard/Cup | Same as single | √ | √ |
DOA-27 | MOP-MET 2 IN1 Test | Saliva | Cassette | 15ng/ml;50ng/ml | √ | Pending |
DK2-11 | K2 Synthetic Cannabis Test | Urine | Strip/Cassette/Dipcard | 200ng/ml | √ | |
DBAR-11 | BAR Barbiturates Test | Urine | Strip/Cassette/Dipcard | 300ng/ml | √ | |
DBUP-11 | BUP Buprenorphine Test | Urine | Strip/Cassette/Dipcard | 10ng/ml | √ | |
DCOT-11 | COT Cotinine Test | Urine | Strip/Cassette/Dipcard | 200ng/ml | √ | |
DEDDP-11 | EDDP Methadone MetaboliteTest | Urine | Strip/Cassette/Dipcard | 100ng/ml | √ | |
DFYL-11 | FYL Fentanyl Test | Urine | Strip/Cassette/Dipcard | 200ng/ml | √ | |
DMTD-11 | MTD Methadone Test | Urine | Strip/Cassette/Dipcard | 300ng/ml | √ | |
DMQL-11 | MQL Methaqualone Test | Urine | Strip/Cassette/Dipcard | 300ng/ml | √ | |
DOPI-11 | OPI Opiate Test | Urine | Strip/Cassette/Dipcard | 2000ng/ml | √ | |
DOXY-11 | OXY Oxycodone Test | Urine | Strip/Cassette/Dipcard | 100ng/ml | √ | |
DPCP-11 | PCP Phencyclidine Test | Urine | Strip/Cassette/Dipcard | 25ng/ml | √ | |
DPPX-11 | PPX Proproxyphene Test | Urine | Strip/Cassette/Dipcard | 300ng/ml | √ | |
DTCA-11 | TCA Tricyclic Antidepressants Test | Urine | Strip/Cassette/Dipcard | 1000ng/ml | √ | |
DTML-11 | TML Tramadol Test | Urine | Strip/Cassette/Dipcard | 200/300ng/ml | √ | |
DAMP-17 | AMP Amphetamine Test | Saliva | Cassette | 50ng/ml | √ | |
DCOT-11 | COT Cotinine Test | Saliva | Cassette | 50ng/ml | √ | |
DKET-17 | KET Ketamine Test | Saliva | Cassette | 200ng/ml | √ | |
DMOP-17 | MOP Morphine Test | Saliva | Cassette | 15ng/ml | √ | |
DMET-17 | MET Methamphetamine Test | Saliva | Cassette | 50ng/ml | √ | |
DOPI-17 | OPI Opiate Test | Saliva | Cassette | 40ng/ml | √ | |
DOXY-17 | OXY Oxycodone Test | Saliva | Cassette | 50ng/ml | √ | |
DPCP-17 | PCP Phencyclidine Test | Saliva | Cassette | 10ng/ml | √ | |
DOA-SN1 | Multi-Drug Single Line Panel | Urine | Cassette/Dipcard/Cup | Same as single | √ | |
DOA-MN1 | Multi-Drug Multi Line Cassette | Urine | Cassette/Cup | Same as single | √ | |
DALK-17 | Saliva Alcohol Test | Saliva | Strip | See insert | | |
*Cutoff in blue is the SAMHSA standard. |
Hangzhou Heo Bio-Tech Co., Ltd. is located in Hangzhou, China, and is specialized in the research, development, production, sale and service of Medical Diagnostic Rapid Test kits and Reagents. We mainly supply Fertility, Drug of abuse & Infectious Disease test kits, Antigens, and Antibodies, such as HCG antibodies, and Drug of abuse antigens and antibodies, to the worldwide market. All our products are manufactured with advanced equipment and strict QC procedures in order to maintain high quality.
At present, we offer HCG test kits, MET test kits, HCV test kits, HIV test kits, MOP test kits, THC test kits, KET test kits, and 2(3, 5, 6)-in-1 panel test kits. We also make some veterinary test kits, like Ractopamine test kits. We are committed to enhancing our quality, continuously developing and providing a variety of quality products. We have made a GMP room to assure our products, and we attained ISO9001 and ISO13485 certifications in 2008.
As our business is expanding rapidly, we are also looking for distributors and OEM partners worldwide. For we provide materials by ourselves, we are sure our price is lower than others. If you are interested in any of our series, please contact us with your detailed inquiries. We hope to have the opportunity of working together with all companies for mutual successes.